Also called: KP-102, Pralmorelin, Pralmorelin Hydrochloride
GHRP-2 is a man-made chain of tiny building blocks called amino acids. It is a lab-made copy of a natural body signal called ghrelin. Ghrelin is the hormone that makes you feel hungry. GHRP-2 tells a part of the brain to release more growth hormone. Growth hormone is a body chemical that helps with growing, healing, and burning fat.
Scientists have studied GHRP-2 mostly in labs and in animal tests. It works by fitting into the same switches on cells that hunger hormones use. When it turns those switches on, the body releases a burst of growth hormone. Some people in fitness and bodybuilding groups have used it, hoping it would help build muscle or burn fat. Some also said it made them feel very hungry.
There are big problems to know about. GHRP-2 is not an approved medicine anywhere. The US food and drug agency put it in a group of substances that may have serious safety risks, including reported deaths. It is not legal for pharmacies to mix it into medicines. Products sold online are not checked for purity, so you cannot be sure what is in them. Scientists still do not know if it is safe for people, so doctors warn against using it.
Benefits
The main themes across 23 research studies, in plain language.
Studies indicate potential benefits for increasing muscle mass, strength, and exercise recovery through anabolic pathways.
Research points to potential improvements in bone density and skeletal growth, particularly in deficient states.
Research suggests GHRP-2 acts as a potent stimulator of growth hormone secretion, often used in diagnostic settings.
Evidence indicates that combining this peptide with GHRH analogs creates a synergistic effect, amplifying growth hormone release.
Studies suggest a favorable secondary hormone profile compared to similar peptides, with moderate effects on cortisol.
Research suggests the peptide may accelerate wound healing and improve skin quality through collagen synthesis.
Studies demonstrate anti-inflammatory actions that may protect organs like the liver and the immune system during stress.
Findings suggest the compound supports cellular defense mechanisms by suppressing oxidative stress and inhibiting cell death.
Research points to appetite-stimulating effects that may increase caloric intake and support weight gain in specific conditions.
Findings imply a role in promoting fat loss and improving overall body composition by reducing fat mass.
Animal studies indicate potential cardioprotective properties, including the reduction of heart fibrosis and oxidative stress.
Preliminary research suggests neuroprotective effects that may improve memory and reduce markers of brain inflammation.
Evidence suggests the compound may enhance sleep depth and quality, particularly slow-wave sleep stages.
Research suggests the peptide may help increase overall energy levels and combat fatigue.
Anecdotal and preliminary evidence suggest it may accelerate recovery from injuries and improve joint comfort.
You just read the research on GHRP-2. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Adverse effects reported in the research and by community use.
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
GHRP-2 (pralmorelin) is a synthetic hexapeptide agonist of the ghrelin receptor (GHSR-1a) on pituitary somatotropes, stimulating potent endogenous GH release (peak GH 30-100 ng/mL). It also increases appetite, mimicking ghrelin. Used as a diagnostic for GH deficiency; not approved therapeutically in the US.
Evidence
Every claim above traces back to a source you can check — here are 6 of them.
Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men
Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN.
General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.
PubChem - Compound - Pralmorelin
ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF
Determinants of GH-releasing hormone and GH-releasing peptide synergy in men
Timeline
Key moments in GHRP-2’s research and regulatory timeline — sourced and dated.
News
Dated, sourced reporting that mentions GHRP-2.
FDA's running list of bulk drug substances that present significant safety risks in compounding names GHRP-2, GHRP-6, ipamorelin acetate, CJC-1295 and AOD-9604. GHRP-2 and GHRP-6 were added to the 503B risk list on September 29, 2023 over immunogenicity concerns, and FDA notes serious adverse events for CJC-1295 (increased heart rate, systemic vasodilatory reactions). The list confirms these peptides are treated by FDA as unsafe-for-compounding substances.
FDA warned Tailor Made Compounding LLC (Nicholasville, KY) after a 2018 inspection found it compounded drug products with bulk substances ineligible for 503A exemptions. The letter explicitly lists the compounded substances: Follistatin, GHRP-2, GHRP-6, AOD 9604, BPC 157, Bremelanotide (PT-141), Cerebrolysin, DSIP, Epitalon, GHK-Cu, Ipamorelin, LL-37, Melanotan II, Selank, Semax, and CJC 1295, among others. The firm was cited for insanitary aseptic processing (adulteration), unapproved new drugs, and misbranding, and removed GHRP-2 and GHRP-6 from its formulary in response.
Wondering how GHRP-2 pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →Explore by goal
Related peptides
Compare
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.